Abstract:BACKGROUND Gastric cancer (GC) is one of the most aggressive malignancies with limited therapeutic options and a poor prognosis. Resveratrol, a non-flavonoid polyphenolic compound found in a variety of Chinese medicinal materials, has shown excellent anti-GC effect. However, its exact mechanisms of action in GC have not been clarified. AIM To identify the effects of resveratrol on GC progression and explore the related molecular mechanisms. METHODS Action targets of resveratrol and GC-related targets were screened from public databases. The overlapping targets between the two were confirmed using a Venn diagram, and a "Resveratrol-Target-GC" network was constructed using Cytoscape software version 3.9.1. The protein-protein interaction (PPI) network was constructed using STRING database and core targets were identified by PPI network analysis. The Database for Annotation, Visualization and Integrated Discovery database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A "Target-Pathway" network was created by using Cytoscape 3.9.1. The RNA and protein expression levels of core target genes were observed using the Cancer Genome Atlas and the Human Protein Atlas databases. DriverDBv3 and Timer2.0 databases were used for survival and immune infiltration analysis. Subsequently, the findings were further verified by molecular docking technology and in vitro experiments. RESULTS A total of 378 resveratrol action targets and 2154 GC disease targets were obtained from public databases, and 181 intersection targets between the two were screened by Venn diagram. The top 20 core targets were identified by PPI network analysis of the overlapping targets. GO function analysis mainly involved protein binding, identical protein binding, cytoplasm, nucleus, negative regulation of apoptotic process and response to xenobiotic stimulus. KEGG enrichment analysis suggested that the involved signaling pathways mainly included PI3K-AKT signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, ErbB signaling pathway, etc . FBJ murine osteosarcoma viral oncogene homolog (FOS) and matrix metallopeptidase 9 (MMP9) were selected by differential expression analysis, and they were closely associated with immune infiltration. Molecular docking results showed that resveratrol docked well with these two targets. Resveratrol treatment arrested the cell cycle at the S phase, induced apoptosis, and weakened viability, migration and invasion in a dose-dependent manner. Furthermore, resveratrol could exhibit anti-GC effect by regulating FOS and MMP9 expression. CONCLUSION The anti-GC effects of resveratrol are related to the inhibition of cell proliferation, migration, invasion and induction of cell cycle arrest and apoptosis by targeting FOS and MMP9.

Identification of Glutathione Sulfotransferase-Pi (GSTP1) As a New Resveratrol Targeting Protein (RTP) and Studies of Resveratrol-Responsive Protein Changes by Resveratrol Affinity Chromatography.

Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation

Quantitative Chemical Proteomics Reveals Resveratrol Inhibition of A549 Cell Migration Through Binding Multiple Targets to Regulate Cytoskeletal Remodeling and Suppress EMT

Quantitative Chemical Proteomics Reveals Resveratrol Inhibition of A549 Cell Migration Through Binding Multiple Targets to Regulate Cytoskeleton Remodeling and Suppress EMT

Cytotoxic, Antiangiogenic and Antitelomerase Activity of Glucosyl- and Acyl- Resveratrol Prodrugs and Resveratrol Sulfate Metabolites

Comparative profiling of analog targets: a case study on resveratrol for mouse melanoma metastasis suppression.

Glutathione S-transferases P1 Protects Breast Cancer Cell from Adriamycin-Induced Cell Death Through Promoting Autophagy

Identification of GSTP1 transferred by extracellular vesicles responsible for adriamycin-resistance in breast cancer cells

Resveratrol Regulates Hsp60 in HEK 293T Cells During Activation of SIRT1 Revealed by Nascent Protein Labeling Strategy

Transformation of Alkylating Regimen of Thiotepa into Tepa Determines the Disease Progression Through GSTP1 Gene Polymorphism for Metastatic Breast Cancer Patients Receiving Thiotepa Containing Salvage Chemotherapy

Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines

The Transport and Uptake of Resveratrol Mediated via Glucose Transporter 1 and Its Antioxidant Effect in Caco-2 Cells

Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer

Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin

Screening of Α-Tocopherol Transfer Protein Sensitive Genes in Human Hepatoma Cells (Hepg2)

A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression

Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol

Comprehensive Characterization of SGTP-Binding Proteins by Orthogonal Quantitative SGTP-Affinity Profiling and SGTP/GTP Competition Assays

Near-infrared frequency upconversion probe for revealing the relationship between glutathione S-transferase and drug-resistance

The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells

Quantification of Desoxyrhapontigenin (4-Methoxyresveratrol) in Rat Plasma by LC–MS/MS: Application to Pre-Clinical Pharmacokinetic Study